Medicaid showed an increasing trend over time in the number of patients initiating novel DMD treatments, with 1 patient in 2016 and 91 patients in 2018.
← all excerpts
Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care.
1
—
—